Industries > Pharma > Cell Therapy Technologies Market Forecast 2020-2030

Back to Pharma Reports

Cell Therapy Technologies Market Forecast 2020-2030

Consumables, Equipment, System & Software, Cell Processing, Cell Processing Equipment, Single Use Equipment, Cell Preservation, Distribution, Handling, Process Monitoring & Quality Control, Human Cells, Animal Cells, Life Sciences & Research Companies, Research Institutes

PUBLISHED: 19 February 2020

PAGES: 201

PRODUCT CODE: PHA0714

SUBMARKET: Biotechnology

SKU: PHA0714 Categories: Biotechnology, Pharma Tags: PHA0714, PHA0718

Visiongain estimates that the global cell therapy technologies market will grow at a CAGR of 15% in the first half of the forecast period. In 2020, North America is estimated to hold 38% of the global cell therapy technologies market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 201-page report you will receive 104 tables and 110 figures– all unavailable elsewhere.

The 201-page report provides clear detailed insight into the cell therapy technologies market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Cell Therapy Technologies Market from 2020-2030

• Forecast of the Global Cell Therapy Technologies Market by Type of Product:
• Consumables
• Equipment: Cell Processing Equipment, Single Use Equipment, Other Equipment
• System & Software

• Forecast of the Global Cell Therapy Technologies by Process Type:
• Cell processing
• Cell preservation, distribution and handling
• Process monitoring and quality control

• Forecast of the Global Cell Therapy Technologies by Cell Type:
• Human cells: Stem cells, Differentiated cells
• Animal cells

• Forecast of the Global Cell Therapy Technologies by End User:
• Life Sciences and Research Companies
• Research Institutes

• This report provides individual revenue forecasts to 2030 for these national markets:
• The US
• Canada
• Mexico
• UK
• Germany
• France
• Italy
• Spain
• Japan
• China
• India
• South Korea
• Singapore
• Malaysia
• Russia
• Brazil
• Argentina
• UAE
• South Africa
• Nigeria
• Mexico

• Our study discusses the selected leading companies that are the major players in the respiratory inhalers market:
• GE Healthcare
• Lonza Group
• Merck KGaA
• Terumo Bct, Inc.
• Thermo Fisher Scientific, Inc.
• & Other Companies

• For the leading companies, we feature product portfolios, business segment breakdowns, recent developments & key expansion strategies etc.

• This report discusses factors that drive and restrain this market. As well as opportunities and challenges faced by this market.

• This report discusses the Porter’s Five Forces Analysis of the Cell Therapy Technologies Market.

• Key questions answered by this report:
• How is the Cell Therapy Technologies Market evolving?
• What is driving and restraining factors of the Cell Therapy Technologies Market?
• What are the market shares of each segment of the overall Cell Therapy Technologies Market in 2020?
• How will each Cell Therapy Technologies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2030?
• How will the market shares for each Cell Therapy Technologies submarket develop from 2021 to 2030?
• What will be the main driver for the overall market from 2021 to 2030?
• Will leading national Cell Therapy Technologies Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2030 and which geographical region will lead the market in 2030?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve during the period between 2020 and 2030?

Visiongain’s study is intended for anyone requiring commercial analyses for the Cell Therapy Technologies Market. You find data, trends and predictions.

Buy our report today Global Cell Therapy Technologies Market : Consumables, Equipment, System & Software, Cell Processing, Cell Processing Equipment, Single Use Equipment, Cell Preservation, Distribution, Handling, Process Monitoring & Quality Control, Human Cells, Animal Cells, Life Sciences & Research Companies, Research Institutes.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

1. Report Overview

1.1 Global Cell Therapy Technologies Market Overview

1.2 Market Definition and Methodology

1.3 Cell Therapy Technologies Market Report Structure

1.4 Why You Should Read This Report

1.5 Key Questions Answered by This Analytical Report Include:

1.6 Who is This Report For?

1.7 Methodology

1.8 Frequently Asked Questions (FAQ)

1.9 Associated Visiongain Reports

1.10 About Visiongain

2. Introduction to the Cell Therapy Technologies Market

2.1 What is Cell Therapy Technology?

2.2 Type of Cell Therapy Technologies

2.3 Key examples of Cell Therapy Technologies

3. Market Overview Cell Therapy Technologies Market

3.1 Porter’s Five Forces Analysis of Cell Therapy Technologies Market

3.1.1 Moderate supplier Bargaining Power

3.1.2 Low bargaining power of buyer

3.1.3 Low-level threats from substitute products

3.1.4 High-level threats from new entrants

3.1.5 High competition from industry players

3.2 Key Competitive Landscape for Cell Therapy Technologies

3.3 Global Cell Therapy Technologies Market Drivers

3.3.1 Emergence of Stem Cell Technology

3.3.2 Rise in Prevalence of Trauma Emergencies and Chronic Diseases

3.3.3 Advancement in Surgical Technologies and Monitoring Devices

3.3.4 Increase in the demand for single-use technologies in bio manufacturing

3.4 Global Cell Therapy Technologies Market Restraints

3.4.1 Operational Inefficiency

3.4.2 Stringent Regulatory Policies & Ethical Issues

3.4.3 High Cost of Treatments

3.5 Global Cell Therapy Technologies Market Opportunities

3.5.1 Opportunities in Stem Cell Applications

3.5.2 Core Competency in Emerging Economies

4. Cell Therapy technologies Market by Product Type 2020-2030

4.1 Cell Therapy Technologies Market for Consumables Forecasts 2020-2030

4.2 Cell Therapy Technologies Market for Equipment Forecasts 2020-2030

4.2.1 Equipment Market by Type 2020-2030

4.2.1.1 Cell Processing Equipment Market Forecasts 2020-2030

4.2.1.2 Single Use Equipment Market Forecasts 2020-2030

4.2.1.3 Other Equipment Market Forecasts 2020-2030

4.3 Cell Therapy Technologies Market for System & Software Forecasts 2020-2030

5. Cell Therapy Technologies Market by Process Type 2020-2030

5.1 Cell Therapy Technologies Market for Cell Processing Forecasts 2020-2030

5.2 Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling Forecasts 2020-2030

5.3 Cell Therapy Technologies Market for Process Monitoring and Quality Control Forecasts 2020-2030

6. Cell Therapy technologies Market by Cell Type 2020-2030

6.1 Cell Therapy Technologies Market for Human Cells Forecasts 2020-2030

6.1.1 Human Cells Market by Type 2020-2030

6.1.1.1 Human Cells Market for Stem Cells Forecasts 2020-2030

6.1.1.2 Human Cells Market for Differentiated Cells Forecasts 2020-2030

6.2 Cell Therapy Technologies Market for Animal Cells Forecasts 2020-2030

7. Cell Therapy Technologies Market by End User: Forecast & Analysis 2020-2030

7.1 Cell Therapy Technologies Market for Life Sciences and Research Company Forecasts 2020-2030

7.2 Cell Therapy Technologies Market for Research Institutes Forecasts 2020-2030

8. Regional Cell Therapy Technologies Market Forecasts 2020-2030

8.1 North American Cell Therapy Technologies Market Forecasts 2020-2030

8.1.1 North America Cell Therapy Technologies Market Forecasts by Country 2020-2030

8.1.1.1 U.S. Cell Therapy Technologies Market Forecasts 2020-2030

8.1.1.2 Canada Cell Therapy Technologies Market Forecasts 2020-2030

8.1.1.3 Mexico Cell Therapy Technologies Market Forecasts 2020-2030

8.1.2 North America Cell Therapy Technologies Market Forecasts by Product Type 2020-2030

8.1.3 North America Cell Therapy Technologies Market Forecasts by Process 2020-2030

8.1.4 North America Cell Therapy Technologies Market Forecasts by Cell Type 2020-2030

8.1.5 North America Cell Therapy Technologies Market Forecasts by End User 2020-2030

8.2 Europe Cell Therapy Technologies Market Forecasts 2021-2030

8.2.1 Europe Cell Therapy Technologies Market Forecasts by Country 2020-2030

8.2.1.1 Germany Cell Therapy Technologies Market Forecasts 2020-2030

8.2.1.2 UK Cell Therapy Technologies Market Forecasts 2020-2030

8.2.1.3 France Cell Therapy Technologies Market Forecasts 2020-2030

8.2.1.4 Russia Cell Therapy Technologies Market Forecasts 2020-2030

8.2.1.5 Spain Cell Therapy Technologies Market Forecasts 2020-2030

8.2.1.6 Italy Cell Therapy Technologies Market Forecasts 2020-2030

8.2.1.7 Rest of Europe Cell Therapy Technologies Market Forecasts 2020-2030

8.2.2 Europe Cell Therapy Technologies Market Forecasts by Product Type 2020-2030

8.2.3 Europe Cell Therapy Technologies Market Forecasts by Process 2020-2030

8.2.4 Europe Cell Therapy Technologies Market Forecasts by Cell Type 2020-2030

8.2.5 Europe Cell Therapy Technologies Market Forecasts by End User 2020-2030

8.3 Asia-Pacific Cell Therapy Technologies Market Forecasts 2020-2030

8.3.1 Asia Pacific Cell Therapy Technologies Market Forecasts by Country 2020-2030

8.3.1.1 China Cell Therapy Technologies Market Forecasts 2020-2030

8.3.1.2 Japan Cell Therapy Technologies Market Forecasts 2020-2030

8.3.1.3 India Cell Therapy Technologies Market Forecasts 2020-2030

8.3.1.4 South Korea Cell Therapy Technologies Market Forecasts 2020-2030

8.3.1.5 Singapore Cell Therapy Technologies Market Forecasts 2020-2030

8.3.1.6 Malaysia Cell Therapy Technologies Market Forecasts 2020-2030

8.3.1.7 Rest of Asia Pacific Cell Therapy Technologies Market Forecasts 2020-2030

8.3.2 Asia Pacific Cell Therapy Technologies Market Forecasts by Product Type 2020-2030

8.3.3 Asia Pacific Cell Therapy Technologies Market Forecasts by Process 2020-2030

8.3.4 Asia Pacific Cell Therapy Technologies Market Forecasts by Cell Type 2020-2030

8.3.5 Asia Pacific Cell Therapy Technologies Market Forecasts by End User 2020-2030

8.4 Rest of the World (RoW) Cell Therapy Technologies Market Forecasts 2020-2030

8.4.1 RoW Cell Therapy Technologies Market Forecasts by Country 2020-2030

8.4.1.1 Brazil Cell Therapy Technologies Market Forecasts 2020-2030

8.4.1.2 Argentina Cell Therapy Technologies Market Forecasts 2020-2030

8.4.1.3 UAE Cell Therapy Technologies Market Forecasts 2020-2030

8.4.1.4 Saudi Arabia Cell Therapy Technologies Market Forecasts 2020-2030

8.4.1.5 South Africa Cell Therapy Technologies Market Forecasts 2020-2030

8.4.1.6 Nigeria Cell Therapy Technologies Market Forecasts 2020-2030

8.4.1.7 Rest of ROW Cell Therapy Technologies Market Forecasts 2020-2030

8.4.2 RoW Cell Therapy Technologies Market Forecasts by Product Type 2020-2030

8.4.3 RoW Cell Therapy Technologies Market Forecasts by Process 2020-2030

8.4.4 RoW Cell Therapy Technologies Market Forecasts by Cell Type 2020-2030

8.4.5 RoW Cell Therapy Technologies Market Forecasts by End User 2020-2030

9. Leading Companies in the Cell Therapy Technologies Market

9.1 ThermoFisher Scientific Inc.

9.1.1 ThermoFisher Scientific Inc.: Business Overview

9.1.2 ThermoFisher Scientific Inc.: Product Portfolio

9.1.3 ThermoFisher Scientific Inc.: Financial Overview

9.1.4 ThermoFisher Scientific Inc.: Recent Developments

9.2 Sartorius Group

9.2.1 Sartorius Group: Business Overview

9.2.2 Sartorius Group: Product Portfolio

9.2.3 Sartorius Group: Financial Overview

9.2.4 Sartorius Group: Recent Developments

9.3 Merck KGaA

9.3.1 Merck KGaA: Business Overview

9.3.2 Merck KGaA: Product Portfolio

9.3.3 Merck KGaA: Financial Overview

9.3.4 Merck KGaA: Recent Developments

9.4 General Electric Company (GE Healthcare)

9.4.1 General Electric Company (GE Healthcare): Business Overview

9.4.2 GE Healthcare: Product Portfolio

9.4.3 General Electric Company: Financial Overview

9.4.4 General Electric Company: Recent Developments

9.5 Danaher Corporation

9.5.1 Danaher Corporation: Business Overview

9.5.2 Danaher Corporation: Product Portfolio

9.5.3 Danaher Corporation: Financial Overview

9.5.4 Danaher Corporation: Recent Developments

9.6 Terumo BCT, Inc.

9.6.1 Terumo BCT, Inc.: Business Overview

9.6.2 Terumo BCT, Inc.: Product Portfolio

9.6.3 Terumo BCT, Inc.: Financial Overview

9.6.4 Terumo BCT, Inc.: Recent Developments

9.7 Becton, Dickinson and Company

9.7.1 Becton, Dickinson and Company: Business Overview

9.7.2 Becton, Dickinson and Company: Product Portfolio

9.7.3 Becton, Dickinson and Company: Financial Overview

9.7.4 Becton, Dickinson and Company: Recent Developments

9.8 Lonza Group

9.8.1 Lonza Group: Business Overview

9.8.2 Lonza Group: Product Portfolio

9.8.3 Lonza Group: Financial Overview

9.8.4 Lonza Group: Recent Developments

9.9 Stemcell Technologies

9.9.1 Stemcell Technologies: Product Portfolio

9.9.2 Stemcell Technologies: Recent Developments

9.10 Miltenyi Biotec

9.10.1 Miltenyi Biotec: Product Portfolio

9.10.2 Miltenyi Biotec: Recent Developments

10. Conclusions

10.1 Current Leading Cell Therapy Technologies Market Segments

10.2 Leading Cell therapy technologies Companies

10.3 Leading Regional Markets

10.4 Emerging Cell Therapy Technologies Markets

11. Glossary

Associated Visiongain Reports

Visiongain Report Sales Order Form

Appendix A

About Visiongain

Appendix B

Visiongain report evaluation form

List of Tables

Table 4.1 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by Product Type, ($bn, AGR%, CAGR%) 2020-2030

Table 4.2 Cell Therapy Technologies Market for Consumables: Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 4.3 Cell Therapy Technologies Market for Consumables, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030

Table 4.4 Cell Therapy Technologies Market for Equipment: Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 4.5 Cell Therapy Technologies Market for Equipment, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030

Table 4.6 Equipment Market by Type Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 4.7 Cell Processing Equipment Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 4.8 Single Use Equipment Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 4.9 Other Equipment Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 4.10 Cell Therapy Technologies Market for System & Software: Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 4.11 Cell Therapy Technologies Market for System & Software, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030

Table 5.1 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by Process Type, ($bn, AGR%, CAGR%) 2020-2030

Table 5.2 Cell Therapy Technologies Market for Cell Processing: Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 5.3 Cell Therapy Technologies Market for Cell Processing, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030

Table 5.4 Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling: Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 5.5 Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030

Table 5.6 Cell Therapy Technologies Market for Process Monitoring and Quality Control: Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 5.7 Cell Therapy Technologies Market for Process Monitoring and Quality Control, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030

Table 6.1 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by Cell Type, ($bn, AGR%, CAGR%) 2020-2030

Table 6.2 Cell Therapy Technologies Market for Human Cells: Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 6.3 Cell Therapy Technologies Market for Human Cells, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030

Table 6.4 Human Cells Market by Type Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 6.5 Human Cells Market for Stem Cells Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 6.6 Human Cells Market for Differentiated Cells Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 6.7 Cell Therapy Technologies Market for Animal Cells: Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 6.8 Cell Therapy Technologies Market for Animal Cells, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030

Table 7.1 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by End User, ($bn, AGR%, CAGR%) 2020-2030

Table 7.2 Cell Therapy Technologies Market for Life Sciences and Research Companies: Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 7.3 Cell Therapy Technologies Market for Life Sciences and Research Companies, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030

Table 7.4 Cell Therapy Technologies Market for Research institutes: Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 7.5 Cell Therapy Technologies Market for Research Institutes, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030

Table 8.1 Regional Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.2 North America Cell Therapy Technologies Market, by Country ($bn, AGR%, CAGR%) 2020-2030

Table 8.3 U.S. Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.4 Canada Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.5 Mexico Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.6 North America Cell Therapy Technologies Market Forecasts, by Product Type ($bn, AGR% CAGR%) 2020-2030

Table 8.7 North America Cell Therapy Technologies Market Forecasts, by Process ($bn, AGR% CAGR%) 2020-2030

Table 8.8 North America Cell Therapy Technologies Market Forecasts, by Cell Type ($bn, AGR% CAGR%) 2020-2030

Table 8.9 North America Cell Therapy Technologies Market Forecasts, by End User ($bn, AGR% CAGR%) 2020-2030

Table 8.10 Europe Cell Therapy Technologies Market, by Country ($bn, AGR%, CAGR%) 2020-2030

Table 8.11 Germany Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.12 UK Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.13 France Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.14 Russia Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.15 Spain Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.16 Italy Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.17 Rest of Europe Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.18 Europe Cell Therapy Technologies Market Forecasts, by Product Type ($bn, AGR% CAGR%) 2020-2030

Table 8.19 Europe Cell Therapy Technologies Market Forecasts, by Process ($bn, AGR% CAGR%) 2020-2030

Table 8.20 Europe Cell Therapy Technologies Market Forecasts, by Cell Type ($bn, AGR% CAGR%) 2020-2030

Table 8.21 Europe Cell Therapy Technologies Market Forecasts, by End User ($bn, AGR% CAGR%) 2020-2030

Table 8.22 Asia Pacific Cell Therapy Technologies Market, by Country ($bn, AGR%, CAGR%) 2020-2030

Table 8.23 China Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.24 Japan Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.25 India Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.26 South Korea Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.27 Singapore Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.28 Malaysia Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.29 Rest of Asia Pacific Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.30 Asia Pacific Cell Therapy Technologies Market Forecasts, by Product Type ($bn, AGR% CAGR%) 2020-2030

Table 8.31 Asia Pacific Cell Therapy Technologies Market Forecasts, by Process ($bn, AGR% CAGR%) 2020-2030

Table 8.32 Asia Pacific Cell Therapy Technologies Market Forecasts, by Cell Type ($bn, AGR% CAGR%) 2020-2030

Table 8.33 Asia Pacific Cell Therapy Technologies Market Forecasts, by End User ($bn, AGR% CAGR%) 2020-2030

Table 8.34 Rest of the World (RoW) Cell Therapy Technologies Market, by Country ($bn, AGR%, CAGR%) 2020-2030

Table 8.35 Brazil Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.36 Argentina Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.37 UAE Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.38 Saudi Arabia Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.39 South Africa Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.40 Nigeria Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2020

Table 8.41 Rest of ROW Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030

Table 8.42 RoW Cell Therapy Technologies Market Forecasts, by Product Type ($bn, AGR% CAGR%) 2020-2030

Table 8.43 RoW Cell Therapy Technologies Market Forecasts, by Process ($bn, AGR% CAGR%) 2020-2030

Table 8.44 RoW Cell Therapy Technologies Market Forecasts, by Cell Type ($bn, AGR% CAGR%) 2020-2030

Table 8.45 RoW Cell Therapy Technologies Market Forecasts, by End User ($bn, AGR% CAGR%) 2020-2030

Table 9.1 ThermoFisher Scientific Inc.: Business Overview

Table 9.2 ThermoFisher Scientific Inc.: Product Portfolio

Table 9.3 ThermoFisher Scientific Inc.: Recent Developments

Table 9.4 Sartorius Group: Business Overview

Table 9.5 Sartorius Group: Product Portfolio

Table 9.6 Sartorius Group: Recent Developments

Table 9.7 Merck KGaA: Business Overview

Table 9.8 Merck KGaA: Product Portfolio

Table 9.9 Merck KGaA: Recent Developments

Table 9.10 GE Healthcare: Business Overview

Table 9.11 GE Healthcare: Product Portfolio

Table 9.12 GE Healthcare: Recent Developments

Table 9.13 Danaher Corporation: Business Overview

Table 9.14 Danaher Corporation: Product Portfolio

Table 9.15 Danaher Corporation: Recent Developments

Table 9.16 Terumo BCT, Inc.: Business Overview

Table 9.17 Terumo BCT, Inc.: Product Portfolio

Table 9.18 Terumo BCT, Inc.: Recent Developments

Table 9.19 Becton, Dickinson and Company: Business Overview

Table 9.20 Becton, Dickinson and Company: Product Portfolio

Table 9.21 Becton, Dickinson and Company: Recent Developments

Table 9.22 Lonza Group: Business Overview

Table 9.23 Lonza Group: Product Portfolio

Table 9.24 Lonza Group: Recent Developments

Table 9.25 Stemcell Technologies: Product Portfolio

Table 9.26 Stemcell Technologies: Recent Developments

Table 9.27 Miltenyi Biotec: Product Portfolio

Table 9.28 Miltenyi Biotec: Recent Developments

List of Figures

Figure 1.1 Global Cell Therapy Technologies Market Segmentation Overview

Figure 3.2 Global Cell Therapy Technologies Market, Key Strategies share (%)

Figure 3.3 Global Cell Therapy Technologies Market: Leading company with number of strategies

Figure 4.1 Global Cell Therapy Technologies Market by Product Type, 2020 (% Share)

Figure 4.2 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by Product Type, ($bn, AGR%, CAGR%) 2020-2030

Figure 4.3 Cell Therapy Technologies Market for Consumables: Forecasts ($bn), 2020-2030

Figure 4.4 Cell Therapy Technologies Market for Consumables, by Region: Forecasts ($bn), 2020-2030

Figure 4.5 Cell Therapy Technologies Market for Equipment: Forecasts ($bn), 2020-2030

Figure 4.6 Cell Therapy Technologies Market for Equipment, by Region: Forecasts ($bn), 2020-2030

Figure 4.7 Equipment Market by type, 2020 (%share)

Figure 4.8 Cell Processing Equipment Market Forecasts ($bn), 2020-2030

Figure 4.9 Single Use Equipment Market Forecasts ($bn), 2020-2030

Figure 4.10 Other Equipment Market Forecasts ($bn), 2020-2030

Figure 4.11 Cell Therapy Technologies Market for System & Software: Forecasts ($bn), 2020-2030

Figure 4.12 Cell Therapy Technologies Market for System & Software, By Region: Forecasts ($bn), 2020-2030

Figure 5.1 Global Cell Therapy Technologies Market by Process Type, 2020, (% Share)

Figure 5.2 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by Process Type, ($bn, AGR%, CAGR%) 2020-2030

Figure 5.3 Cell Therapy Technologies Market for Cell Processing: Forecasts ($bn), 2020-2030

Figure 5.4 Cell Therapy Technologies Market for Cell Processing, by Region: Forecasts ($bn), 2020-2030

Figure 5.5 Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling: Forecasts ($bn), 2020-2030

Figure 5.6 Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling, by Region: Forecasts ($bn), 2020-2030

Figure 5.7 Cell Therapy Technologies Market for Process Monitoring and Quality Control: Forecasts ($bn), 2020-2030

Figure 5.8 Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling, By Region: Forecasts ($bn), 2020-2030

Figure 6.1 Global Cell Therapy Technologies Market by Cell Type, 2020, (% Share)

Figure 6.2 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by Cell Type, ($bn, AGR%, CAGR%) 2020-2030

Figure 6.3 Cell Therapy Technologies Market for Human Cells: Forecasts ($bn), 2020-2030

Figure 6.4 Cell Therapy Technologies Market for Human Cells, By Region: Forecasts ($bn), 2020-2030

Figure 6.5 Human Cells Market by type, 2020 (%share)

Figure 6.6 Human Cells Market for Stem Cells Forecasts ($bn), 2020-2030

Figure 6.7 Human Cells Market for Differentiated Cells Forecasts ($bn), 2020-2030

Figure 6.8 Cell Therapy Technologies Market for Animal Cells: Forecasts ($bn), 2020-2030

Figure 6.9 Cell Therapy Technologies Market for Animal Cells, by Region: Forecasts ($bn), 2020-2030

Figure 7.1 Global Cell Therapy Technologies Market by End User, 2020, (% Share)

Figure 7.2 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by End User, ($bn, AGR%, CAGR%) 2020-2030

Figure 7.3 Cell Therapy Technologies Market for Life Sciences and Research Companies: Forecasts ($bn), 2020-2030

Figure 7.4 Cell Therapy Technologies Market for Life Sciences and Research Companies, Market Share 2030

Figure 7.5 Cell Therapy Technologies Market for Life Sciences and Research Companies, By Region: Forecasts ($bn), 2020-2030

Figure 7.6 Cell Therapy Technologies Market for Research Institutes: Forecasts ($bn), 2020-2030

Figure 7.7 Cell Therapy Technologies Market for Research Institutes, by Region: Forecasts ($bn), 2020-2030

Figure 8.1 Regional Cell Therapy Technologies Markets Forecasts ($bn), 2020-2030

Figure 8.2 North America Cell Therapy Technologies Market Share Analysis, by Country (%), 2020

Figure 8.3 U.S. Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.4 Canada Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.5 Mexico Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.6 North America Cell Therapy Technologies Market Revenue Analysis, by Product Type, 2020-2030

Figure 8.7 North America Cell Therapy Technologies Market Revenue Analysis, by Process, 2020-2030

Figure 8.8 North America Cell Therapy Technologies Market Revenue Analysis, by Cell Type, 2020-2030

Figure 8.9 North America Cell Therapy Technologies Market Revenue Analysis, by End User, 2020-2030

Figure 8.10 Europe Cell Therapy Technologies Market Share Analysis, by Country (%), 2020

Figure 8.11 Germany Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.12 UK Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.13 France Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.14 Russia Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.15 Spain Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.16 Italy Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.17 Rest of Europe Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.18 Europe Cell Therapy Technologies Market Revenue Analysis, by Product Type, 2020-2030

Figure 8.19 Europe Cell Therapy Technologies Market Revenue Analysis, by Process, 2020-2030

Figure 8.20 Europe Cell Therapy Technologies Market Revenue Analysis, by Cell Type, 2020-2030

Figure 8.21 Europe Cell Therapy Technologies Market Revenue Analysis, by End User, 2020-2030

Figure 8.22 Asia Pacific Cell Therapy Technologies Market Share Analysis, by Country (%), 2020

Figure 8.23 China Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.24 Japan Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.25 India Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.26 South Korea Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.27 Singapore Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.28 Malaysia Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.29 Rest of Asia Pacific Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.30 Asia Pacific Cell Therapy Technologies Market Revenue Analysis, by Product Type, 2020-2030

Figure 8.31 Asia Pacific Cell Therapy Technologies Market Revenue ($bn) Analysis, by Process, 2020-2030

Figure 8.32 Asia Pacific Cell Therapy Technologies Market Revenue Analysis, by Cell Type, 2020-2030

Figure 8.33 Asia Pacific Cell Therapy Technologies Market Revenue Analysis, by End User, 2020-2030

Figure 8.34 Rest of the World (RoW) Cell Therapy Technologies Market Share Analysis, by Country (%), 2020

Figure 8.35 Brazil Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.36 Argentina Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.37 UAE Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.38 Saudi Arabia Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.39 South Africa Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.40 Nigeria Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.41 Rest of ROW Cell Therapy Technologies Market Forecasts ($bn), 2020-2030

Figure 8.42 RoW Cell Therapy Technologies Market Revenue Analysis, by Product Type, 2020-2030

Figure 8.43 RoW Cell Therapy Technologies Market Revenue Analysis, by Process, 2020-2030

Figure 8.44 RoW Cell Therapy Technologies Market Revenue Analysis, by Cell Type, 2020-2030

Figure 8.45 RoW Cell Therapy Technologies Market Revenue Analysis, by End User, 2020-2030

Figure 9.1 ThermoFisher Scientific Inc. Annual Revenue 2014-2018 ($million)

Figure 9.2 ThermoFisher Scientific Inc.: Business Segment Revenue share 2018 (%)

Figure 9.3 ThermoFisher Scientific Inc.: Product Segment Revenue share 2018 (%)

Figure 9.4 ThermoFisher Scientific Inc.: Geography Segment Revenue share 2018 (%)

Figure 9.5 Sartorius Group: Annual Revenue 2014-2018 ($million)

Figure 9.6 Sartorius Group: Business Segment Revenue share 2018 (%)

Figure 9.7 Sartorius Group: Geography Segment Revenue share 2018 (%)

Figure 9.8 Merck KGaA: Annual Revenue 2014-2018 ($million)

Figure 9.9 Merck KGaA: Business Segment Revenue share 2018 (%)

Figure 9.10 Merck KGaA: Geography Segment Revenue share 2018 (%)

Figure 9.11 General Electric Company: Annual Revenue 2014-2018 ($million)

Figure 9.12 General Electric Company: Business Segment Revenue share 2018(%)

Figure 9.13 General Electric Company: Geography Segment Revenue share 2018 (%)

Figure 9.14 Danaher Corporation: Annual Revenue 2014-2018 ($million)

Figure 9.15 Danaher Corporation: Business Segment Revenue share 2018(%)

Figure 9.16 Danaher Corporation: Geography Segment Revenue share 2018 (%)

Figure 9.17 Terumo BCT, Inc.: Annual Revenue 2014-2018 ($million)

Figure 9.18 Terumo BCT, Inc.: Business Segment Revenue share 2018(%)

Figure 9.19 Terumo BCT, Inc.: Geography Segment Revenue share 2018 (%)

Figure 9.20 Becton, Dickinson and Company: Annual Revenue 2015-2019 ($million)

Figure 9.21 Becton, Dickinson and Company: Business Segment Revenue share 2019 (%)

Figure 9.22 Becton, Dickinson and Company: Geography Segment Revenue share 2019 (%)

Figure 9.23 Lonza Group: Annual Revenue 2014-2018 ($million)

Figure 9.24 Lonza Group: Business Segment Revenue share 2018 (%)

Figure 9.25 Lonza Group: Geography Segment Revenue share 2018 (%)

Figure 10.1 Cell Therapy Technologies Market Analysis, by Regions ($bn, AGR%), 2020-2030

Affymetrix, Inc.

Akouos

AllCells

Applikon Biotechnology Inc.

ATLATL Centre

Autolus Limited

Beckman Coulter, Inc.

Becton, Dickinson and Company

Bioengineering AG

Biological Industries

BioWa, Inc

Brammer Bio

C.R. Bard, Inc.

CaridianBCT, Inc

Cell and Gene Therapy Asia Technology Centre

Centre for Process Innovation (CPI)

CMC Biologics (Asahi Glass Co.)

Cobra Biologics

Cocoon Platform

Cryoport

Danaher Corporation

DiNAQOR AG

EMD Performance Materials

EMD Serono

Eppendorf AG

European Molecular Biology Laboratory (EMBL)

Finesse Solutions, Inc.

Flexsafe RM TX

FloDesign Sonics

FlowJo, LLC

Food and Drug Administration (FDA)

Gamida Cell

G-CON Manufacturing

GE healthcare

GenScript

Infors HT

Integrated DNA Technologies, Inc.

LaVision BioTec

Lonza Group, GE Healthcare

Massachusetts Eye and Ear (MEE)

Meissner Filtration Products, Inc.

Merck KGaA

Merck Serono

Mesoblast

MilliporeSigma

Miltenyi Biotec

Nova Biomedical

Pall Corporation (Pall)

Patheon N.V.

Penn State University

PharmaCell B.V

Sartorius AG

Sartorius Stedim Biotech

Scinogy

Selecta Biosciences, Inc

Siemens

Solaris Biotech

Stafa Cellular Therapy

StafaCT

Stemcell Technologies

Terumo Bct, Inc. (A Subsidiary of Terumo Corporation)

Thermo Fisher Scientific, Inc.

Tillotts Pharma AG

Transtem Lab

UniCAR Therapy

World Courier

Download sample pages

Complete the form below to download your free sample pages for Cell Therapy Technologies Market Forecast 2020-2030

Download sample pages

Complete the form below to download your free sample pages for Cell Therapy Technologies Market Forecast 2020-2030

Case studies

Need customized work?

Report overview

Methodology

Client testimonials

Pharmaceutical industry associations

American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Connect with us

Visiongain Pharma

Latest Pharma news

Visiongain Publishes Bioreactors Market Report 2023-2033

The global Bioreactors market was estimated to be valued at US$ 9,9770.0 million in 2023 and is expected to register a CAGR of 12.2% from 2023 to 2033.

29 September 2023

READ

Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033

The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.

27 September 2023

READ

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033

The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.

25 September 2023

READ

Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033

The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.

21 September 2023

READ

Industries > Pharma > Cell Therapy Technologies Market Forecast 2020-2030

Back to Pharma Reports

Cell Therapy Technologies Market Forecast 2020-2030

Consumables, Equipment, System & Software, Cell Processing, Cell Processing Equipment, Single Use Equipment, Cell Preservation, Distribution, Handling, Process Monitoring & Quality Control, Human Cells, Animal Cells, Life Sciences & Research Companies, Research Institutes

Download sample pages

Related reports

Global Rheumatoid Arthritis Drugs Market Forecast 2020-2030

Global Pharma Contract Sales Market Forecast 2020-2030

Global Contract Research Organisations (CROs) Market Report Forecasts 2020-2030

Global Bioreactors Market 2020-2030

Global Stem Cell Technologies and Applications Market 2019-2029

Global Precision Medicine Market Forecast 2019-2029

Translational Regenerative Medicine Market Forecast 2020-2030

Biobanking Market Forecasts 2019-2029

The Global Respiratory Inhalers Market 2020-2030

Biologics Market Trends and Forecasts 2019-2029

Download sample pages

Share

Connect with us

Latest Pharma news

Visiongain Publishes Bioreactors Market Report 2023-2033

Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033

Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033

Our Clients